Company intelligence / Profile preview

Phitonex

Durham, North Carolina, United Statesthermofisher.com ↗

Ownership: Private
Development stage: Commercial

Overview

Phitonex developed a proprietary DNA nanotechnology-based platform to create highly customizable fluorescent nanoparticles ("Phitons™") and spectral dyes for high-resolution single-cell analysis by flow cytometry. Their products enabled lower noise, less spectral overlap, and higher multiplexing in cell analysis applications. The company was acquired by Thermo Fisher Scientific in December 2020 to enhance Thermo Fisher’s capabilities in protein and cell analysis research.

Modalities: DeviceNanoparticle
Industry: Consumable Medical Devices

Partnerships

Thermo Fisher Scientific

Beyond the preview

Go deeper on Phitonex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phitonex.

Explore the full profile